Forward-looking and aligned with the UAE’s growth in medical innovation.
As the UAE continues to develop its advanced care infrastructure in haematology, oncology, and organ transplantation, cytomegalovirus (CMV) remains a persistent threat to patient outcomes—especially among immunocompromised individuals. Letermovir, a targeted antiviral agent, has emerged as a vital prophylactic tool in the post-transplant setting, dramatically reducing CMV-related complications in high-risk populations.
With stem cell transplant programs expanding in both public and private healthcare sectors, the demand for high-purity Letermovir API is growing rapidly. At MedicaPharma, we support UAE-based pharmaceutical developers and compounding pharmacies with premium-grade Letermovir, backed by rigorous quality controls, full documentation, and reliable global logistics.
Download GMP-Certified API Product List
MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations. Click here to download our complete API product list.
“Medicapharma’s products and services are exclusively available to licensed companies and professionals. We do not sell to individuals or private consumers.”
Get your requested raw materials quotation
Table of Contents
What is Letermovir? A Targeted Approach to CMV Prevention
Letermovir is an antiviral compound specifically designed to prevent reactivation of human cytomegalovirus (CMV)—a common but potentially life-threatening pathogen in immunosuppressed patients. CMV is particularly dangerous in recipients of allogeneic hematopoietic stem cell transplantation (HSCT), where it can lead to serious complications such as pneumonia, gastrointestinal disease, hepatitis, and even graft failure.
Mechanistically, Letermovir is a CMV DNA terminase complex inhibitor—a novel class of antivirals that prevents viral DNA processing and packaging into infectious virions.
Unlike ganciclovir or foscarnet, Letermovir has no known myelotoxicity or nephrotoxicity, making it significantly safer for transplant patients who are already at risk of bone marrow suppression and kidney injury.
It is currently approved for CMV prophylaxis in CMV-seropositive adult recipients of HSCT, and has been included in several international guidelines for transplant care.
Get your requested raw materials quotation
The UAE’s Growing Transplant Capabilities
The UAE has made significant strides in the development of specialised care, including the introduction of stem cell transplant programs in centres like Abu Dhabi Stem Cells Center (ADSCC) and transplant units across major hospitals in Dubai and Sharjah. As transplant activity increases, so does the importance of effective infection prevention strategies, particularly against opportunistic viruses such as CMV.
Pharmaceutical manufacturers and compounders in the UAE now face the dual challenge of developing advanced antiviral formulations while also maintaining compliance with stringent regulatory and quality standards. A reliable supply of GMP-grade Letermovir API is essential to meet this demand—and that’s where MedicaPharma steps in.
Get your requested raw materials quotation
Why Choose MedicaPharma for Letermovir API?
At MedicaPharma, we specialise in the supply of high-quality active pharmaceutical ingredients for use in compounding and formulation development. Our Letermovir API is produced under strict GMP conditions and delivered with a complete documentation package to ensure full compliance with UAE and international pharmaceutical regulations.
Each batch of Letermovir is accompanied by a Certificate of Analysis, MSDS, and TSE/ BSE-free declarations, offering you peace of mind on quality, safety, and traceability. Our technical team supports clients throughout the sourcing and formulation process—from documentation to logistics and import coordination.
We work only with certified manufacturers who meet EU and FDA standards. The result is an API that not only meets purity and potency specifications but also performs reliably in finished formulations for oral or injectable use.
In addition to our stringent quality controls, we offer competitive pricing with flexible quantity options, allowing both clinical-scale and commercial-scale buyers in the UAE to source efficiently. Our logistics team ensures fast, temperature-controlled shipments to the Emirates, with experience navigating the unique customs and regulatory landscape of the GCC.
Formulation Possibilities for UAE Compounders
Letermovir is most commonly formulated as:
- Oral tablets or capsules, for once-daily dosing
- Oral suspensions, where dose adjustments are required or for patients with swallowing difficulties
- Sterile solutions for injection, typically used in a hospital setting for immediate bioavailability
Given its excellent safety profile and low drug-drug interaction risk, Letermovir is increasingly being considered for broader antiviral prophylaxis in immunocompromised populations beyond HSCT—creating new opportunities for formulation innovation in the UAE market.
Whether you’re a licensed compounding pharmacy preparing patient-specific doses, or a pharmaceutical manufacturer developing scalable antiviral solutions, MedicaPharma offers the high-purity Letermovir API and expert support needed to take your formulation from concept to clinic.
MedicaPharma: Your Strategic Supply Partner in the UAE
The MedicaPharma difference lies in more than just our product—it’s in our partnership approach. We understand the real-world needs of pharmaceutical manufacturers, research organisations, and compounding pharmacies across the UAE. We offer:
- GMP-compliant, fully traceable APIs
- Full regulatory documentation support
- Responsive, expert customer service
- Competitive pricing models
- Fast, secure international delivery to the UAE
By working with MedicaPharma, you gain access to a global network of trusted suppliers and a team of pharmaceutical professionals who understand your industry—and your urgency.
Order Letermovir API With Confidence
Letermovir is helping transform post-transplant care for patients at risk of CMV complications. As the UAE continues to lead in advanced transplant and infectious disease care, the need for reliable, high-quality active ingredients will only grow.
MedicaPharma is proud to support that progress with a product and service offering that meets the highest standards of quality, reliability, and compliance.
Request your Letermovir quote today
Start sourcing smarter—partner with MedicaPharma for pharmaceutical-grade excellence.
Get a Fast and Easy GMP-Certified API Quote
Focus on your compounding pharmacy business and let MedicaPharma take care of your APIs. Obtaining a quote is easy
“Medicapharma’s products and services are exclusively available to licensed companies and professionals. We do not sell to individuals or private consumers.”
